Drug and Therapeutics Bulletin · Nov 13, 2026

Amiloride in hypertension: mechanisms, clinical use and emerging perspectives

By Amran M, Faconti L

Amiloride hydrochloride is a potassium-sparing diuretic that has been available for several decades but remains relatively underused in the management of hypertension. It acts by blocking epithelial sodium channels in the distal nephron, leading to modest natriuresis and potassium retention. Although traditionally used as an adjunct to thiazide or loop diuretics, interest in amiloride has increased following evidence from mechanistic and clinical studies suggesting efficacy in blood pressure reduction, including in resistant hypertension. More recent trials demonstrated favourable metabolic effects compared with thiazide diuretics and non-inferiority to spironolactone in lowering blood pressure in resistant hypertension over short-term follow-up. Despite these findings, evidence for long-term cardiovascular outcomes with amiloride is lacking. Its current role remains largely as an adjunct or alternative in selected patients, particularly where spironolactone is not tolerated or where metabolic concerns limit thiazide use. Further studies are required to define its place more precisely within contemporary hypertension management.

doi.org/10.1136/dtb.2026.000014Interventions

AgingResearch.News